Overview A Study of Nerve Blocks for Migraines Status: Not yet recruiting Trial end date: 2023-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to see how well blocking those nerves with bupivacaine anesthetic (numbing medication) and low dose methylprednisolone (cortisone-like medicine or steroid) work for treating and preventing migraines. Phase: Phase 2 Details Lead Sponsor: Mayo ClinicTreatments: BupivacaineMethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate